Clinical Trials Directory

Trials / Completed

CompletedNCT01534390

Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients

The Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients: A Prospective, Randomized, Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
504 (actual)
Sponsor
University of Salzburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Studies showed that infusion or injection of drugs and fluids results in introduction of microparticles into the bloodstream. These microparticles may cause organ damage and stimulate the immune system thus aggravating the underlying disease. Given that critically ill patients are characteristically suffering from a high disease severity and receive large amounts of fluids and drugs, they may be at particular risk of harm by these microparticles. In-line microfilters have been shown to clear microparticles from intravenous drugs and solutions. The investigators hypothesize that use of in-line microfilters reduce the days with the systemic inflammatory response syndrome in adult critically ill patients.

Conditions

Interventions

TypeNameDescription
DEVICEIn-line microfilter (Supor IV Filter; Pall Corporation, Port Washington, New York)use of in-line microfilters with a pore size of 0,2 mcm and 1,2 mcm (only if parenteral nutrition is administered) at all intravenous accesses

Timeline

Start date
2012-04-01
Primary completion
2013-04-01
Completion
2015-05-01
First posted
2012-02-16
Last updated
2015-06-02

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01534390. Inclusion in this directory is not an endorsement.